__NUXT_JSONP__("/drugs/Nitrogen_Mustard_Prodrug_PR-104", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A non-toxic, small-molecule, hypoxia-activated, 3,5-dinitrobenzamide nitrogen mustard pre-prodrug with potential antitumor activity. Upon intravenous administration, PR-104 is converted by systemic phosphatases to the alcohol intermediate PR-104A, which is reduced to form the active DNA-crosslinking mustard species hydroxylamine PR-104H intracellularly under hypoxic conditions. PR-104H specifically crosslinks hypoxic tumor cell DNA, resulting in the inhibition of DNA repair and synthesis, cell-cycle arrest, and apoptosis in susceptible hypoxic tumor cell populations while sparing normoxic tissues.",fdaUniiCode:"V16D2ZT7DT",identifier:"C61590",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C697"],synonyms:["((2-Bromoethyl)-2,4-dinitro-6-(((2-(phosphonooxy)ethyl)amino)-carbonyl)anilino)ethyl Methanesulphonate",c,"PR-104","PR104"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FNitrogen_Mustard_Prodrug_PR-104",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Nitrogen_Mustard_Prodrug_PR-104","Nitrogen Mustard Prodrug PR-104","2021-10-30T13:41:37.833Z")));